Should NICE Reconsider Inclisiran Recommendation?
Researchers examined NICE’s conclusions on inclisiran’s clinical outcomes, safety, and cost, which they say warrant more transparent data.
All articles by Cardiology Advisor Contributing Writer
Association of Black Cardiologist’s 12th Annual Spirit of the Heart Virtual Gala Awards: Heart Equity in Motion
The 12th annual Spirit of the Heart Virtual Awards Gala & Fundraiser, to be conducted as a virtual event on Saturday, October 16th, from 7:00 PM to 9:00 PM EST, provides an opportunity for individuals to support the efforts of the ABC to remove barriers to optimal heart health in minority populations.
Personalized Antiplatelet Therapy Reduces Ischemic Events in Stable CAD
Personalized antiplatelet therapy using platelet function testing can decrease ischemic events in stable CAD.
Does Hemodynamic-Guided Management of Heart Failure Improve Outcomes?
This study evaluated the effects of hemodynamic-guided management of heart failure on composite mortality and heart failure events.
Acute Idiopathic Pericarditis: Clinical and Economic Outcomes
Researchers evaluated inpatient discharge data from the AHRQ Healthcare Cost and Utilization Project Nationwide Inpatient Sample to assess outcomes associated with acute idiopathic pericarditis.
Low-Dose Colchicine Reduced Ischemic CV Event Risk Irrespective of Prior MI
The anti-inflammatory benefits of colchicine were consistently observed in this study, regardless of specific history and timing of prior ACS.
Adherence to Atrial Fibrillation Pathway Improves Outcomes
Authors performed a systematic review of current evidence for the use of the Atrial Fibrillation Better Care (ABC) pathway and its effect on clinical outcomes.
Dual-Pathway Inhibition in Cardiovascular Disease: Efficacy and Safety
The study authors conducted a systematic review and meta-analysis to assess the overall efficacy and safety of low-dose direct oral anticoagulants vs placebo on a background of antiplatelet therapy.
Therapeutic vs Prophylactic Anticoagulation for Hospitalized COVID-19
Investigators report findings from the ACTION trial assessing outcomes of therapeutic vs prophylactic oral anticoagulant use among hospitalized adult patients with COVID-19 and elevated D-dimer concentration.
Risk for Atrial Fibrillation Higher Among Those With Cancer
Atrial Fibrillation risk was examined for patients with cancer from 2009 through 2017.
- Loading...
Loading...
Next post in Arrhythmia
Loading... 
Loading...